Bile acids regulate intestinal cell proliferation by modulating EGFR and FXR signaling

• Published in: American journal of physiology: Gastrointestinal and liver physiology Vol. 310; no. 2; pp. G81 - G92
• Main Authors: Dossa, Avafia Y, Escobar, Oswaldo, Golden, Jamie, Frey, Mark R, Ford, Henri R, Gayer, Christopher P
• Format: Journal Article
• Language: English
• Published: United States American Physiological Society 15.01.2016
• Subjects: Animals; Bile Acids and Salts - pharmacology; Cell growth; Cell Proliferation - drug effects; Cholic Acid - pharmacology; Deoxycholic Acid - pharmacology; Epidermal growth factor; Hormones, Neurotransmitters, Growth Factors, Receptors, and Signaling; Intestine, Small - drug effects; Intestine, Small - metabolism; Metabolites; Phosphorylation; Phosphorylation - drug effects; Rats; Receptor, Epidermal Growth Factor - metabolism; Receptors, Cytoplasmic and Nuclear - metabolism; necrotizing enterocolitis; intestine; proliferation; bile acid
• ISSN: 0193-1857; 1522-1547
• DOI: 10.1152/ajpgi.00065.2015

Bile acids (BAs) are synthesized in the liver and secreted into the intestine. In the lumen, enteric bacteria metabolize BAs from conjugated, primary forms into more toxic unconjugated, secondary metabolites. Secondary BAs can be injurious to the intestine and may contribute to disease. The epidermal growth factor receptor (EGFR) and the nuclear farnesoid X receptor (FXR) are known to interact with BAs. In this study we examined the effects of BAs on intestinal epithelial cell proliferation and investigated the possible roles for EGFR and FXR in these effects. We report that taurine-conjugated cholic acid (TCA) induced proliferation, while its unconjugated secondary counterpart deoxycholic acid (DCA) inhibited proliferation. TCA stimulated phosphorylation of Src, EGFR, and ERK 1/2. Pharmacological blockade of any of these pathways or genetic ablation of EGFR abrogated TCA-stimulated proliferation. Interestingly, Src or EGFR inhibitors eliminated TCA-induced phosphorylation of both molecules, suggesting that their activation is interdependent. In contrast to TCA, DCA exposure diminished EGFR phosphorylation, and pharmacological or siRNA blockade of FXR abolished DCA-induced inhibition of proliferation. Taken together, these results suggest that TCA induces intestinal cell proliferation via Src, EGFR, and ERK activation. In contrast, DCA inhibits proliferation via an FXR-dependent mechanism that may include downstream inactivation of the EGFR/Src/ERK pathway. Since elevated secondary BA levels are the result of specific bacterial modification, this may provide a mechanism through which an altered microbiota contributes to normal or abnormal intestinal epithelial cell proliferation.